Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

226 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Immune checkpoint blockade therapy mitigates systemic inflammation and affects cellular FLIP-expressing monocytic myeloid-derived suppressor cells in non-progressor non-small cell lung cancer patients.
Adamo A, Frusteri C, Pilotto S, Caligola S, Belluomini L, Poffe O, Giacobazzi L, Dusi S, Musiu C, Hu Y, Wang T, Rizzini D, Vella A, Canè S, Sartori G, Insolda J, Sposito M, Incani UC, Carbone C, Piro G, Pettinella F, Qi F, Wang D, Sartoris S, De Sanctis F, Scapini P, Dusi S, Cassatella MA, Bria E, Milella M, Bronte V, Ugel S. Adamo A, et al. Among authors: bronte v. Oncoimmunology. 2023 Sep 14;12(1):2253644. doi: 10.1080/2162402X.2023.2253644. eCollection 2023. Oncoimmunology. 2023. PMID: 37720688 Free PMC article.
Derangement of immune responses by myeloid suppressor cells.
Serafini P, De Santo C, Marigo I, Cingarlini S, Dolcetti L, Gallina G, Zanovello P, Bronte V. Serafini P, et al. Among authors: bronte v. Cancer Immunol Immunother. 2004 Feb;53(2):64-72. doi: 10.1007/s00262-003-0443-2. Epub 2003 Oct 30. Cancer Immunol Immunother. 2004. PMID: 14593498 Free PMC article. Review.
Role of arginine metabolism in immunity and immunopathology.
Peranzoni E, Marigo I, Dolcetti L, Ugel S, Sonda N, Taschin E, Mantelli B, Bronte V, Zanovello P. Peranzoni E, et al. Among authors: bronte v. Immunobiology. 2007;212(9-10):795-812. doi: 10.1016/j.imbio.2007.09.008. Epub 2007 Nov 14. Immunobiology. 2007. PMID: 18086380 Free article. Review.
Myeloid-derived suppressor cell role in tumor-related inflammation.
Dolcetti L, Marigo I, Mantelli B, Peranzoni E, Zanovello P, Bronte V. Dolcetti L, et al. Among authors: bronte v. Cancer Lett. 2008 Aug 28;267(2):216-25. doi: 10.1016/j.canlet.2008.03.012. Epub 2008 Apr 22. Cancer Lett. 2008. PMID: 18433992 Review.
IL4Ralpha+ myeloid-derived suppressor cell expansion in cancer patients.
Mandruzzato S, Solito S, Falisi E, Francescato S, Chiarion-Sileni V, Mocellin S, Zanon A, Rossi CR, Nitti D, Bronte V, Zanovello P. Mandruzzato S, et al. Among authors: bronte v. J Immunol. 2009 May 15;182(10):6562-8. doi: 10.4049/jimmunol.0803831. J Immunol. 2009. PMID: 19414811
Therapeutic targeting of myeloid-derived suppressor cells.
Ugel S, Delpozzo F, Desantis G, Papalini F, Simonato F, Sonda N, Zilio S, Bronte V. Ugel S, et al. Among authors: bronte v. Curr Opin Pharmacol. 2009 Aug;9(4):470-81. doi: 10.1016/j.coph.2009.06.014. Epub 2009 Jul 16. Curr Opin Pharmacol. 2009. PMID: 19616475 Review.
226 results